Jay is a principal at EY-Parthenon and a leading advisor to global medical technologies and pharmaceutical companies on a wide range of strategy, commercial and M&A issues.
During his 20 years of consulting, Jay has helped more than 100 medical technologies, pharmaceutical and health care companies develop and execute organic and inorganic strategies to drive growth and transformation in the US, Europe, Asia-Pacific and Latin America markets.
Jay’s areas of focus include business unit strategy, market entry strategy, expansion and adjacencies strategy, mergers and acquisitions (M&A), value proposition transformation, business model transformation, go-to-market strategy, new product launch, market access, and commercial model design.
Prior to joining EY-Parthenon in 2021, Jay held various practice and account leadership roles at leading professional services firms and corporations.
How Jay is building a better working world
Jay approaches his client work with a firm belief that strategies fail to deliver results because they are not the right strategies and that a brilliant strategy poorly executed is a myth. As a strategy consultant, Jay works collaboratively with his client teams so that the right strategic choices are made, aligned, communicated and successfully executed to deliver results. He leverages his cross-functional experience, industry know-how, empirical knowledge and value-driven approach to help clients realize growth and long-term success.
In addition to helping clients succeed, Jay is passionate about mentoring and supporting young business professionals and entrepreneurs to realize their full potential.
